The Food and Drug Administration (FDA) has approved Xifyrm ™ (meloxicam injection) for use in adults for the management of moderate to severe pain, alone or in combination with non-NSAID ...

The FDA approved a polypill containing telmisartan, amlodipine, and indapamide, known as Widaplik, for the treatment of ...

Have outer foot pain? Here are common causes of pain on the outer side of your foot, the symptoms to watch for, and how to ...

Early detection and new biomarkers are changing how we manage acute kidney injury—and its link to chronic kidney disease.

Fatigue from ankylosing spondylitis (AS) is more than just feeling tired. Learn how lifestyle changes, medication, and ...

Orthopedic surgeons are evaluated on patient experience through patient-focused surveys, patient-related outcome measures, ...

Azurity Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved XIFYRMtm (meloxicam injection), an IV non-steroidal anti-inflammatory drug (NSAID) that ...

SPF is our summertime BFF — that’s because sunscreen protects us against two types of harmful ultraviolet radiation.

Scioto Properties has surpassed $50 million in acquisition volume during the first five months of 2025, following the most active year in the company's 25-year history in 2024. The milestone reflects ...

Treatment Market is set to acquire a value of USD 11,973.7 million in 2024. By 2034, the value of the psoriatic arthritis (PsA) treatment market is slated to shoot upwards of USD 25,375.6 million. As ...

A Chikungunya outbreak has hit Mombasa County, with health officials confirming at least 25 positive cases following ...

When we think about health red flags, kidney problems don’t always come to mind right away — but maybe they should. Our ...